JavaScript is disabled. Please enable to continue!

Mobile search icon
Eurofins >> Cosmetics >> Media Centre >> News >> Eurofins Cosmetics & Personal Care is building a sustainable and innovative future together with strategic in vitro partnerships

Eurofins Cosmetics & Personal Care is building a sustainable and innovative future with strategic in vitro partnerships

Sidebar Image

 

For more than 30 years, the Eurofins Cosmetics & Personal Care network of companies has been growing, achieving a leadership position by embracing new testing methods and services. As part of our sustainable vision, we are passionate about collaborating with partners to develop game-changing innovations and new testing perspectives to better serve our clients. Thus, we strongly believe that working together is the key to building and accelerating the next generation of in vitro testing.

 

Eurofins Cosmetics & Personal Care focuses on building long-term, transparent and trusted partnerships with strategic companies that have the experience, expertise, knowledge and capabilities to support future in vitro innovation. Our diverse collaborations encompass cutting-edge, leading European start-ups that encourage entrepreneurial thinking, including:

  • CTIBIOTECH provides 3D Bioprinted full skin models (production of 50 to 100 artificial skin models from skin cells from a single donor), in vitro models (different human cell types from skin pre-clinical grade production) and ex vivo biopsy models (including skin, scalp, hair and on-demand tissues).
  • Phenocell provides in vitro assays to Dermatology and Ophtalmology Research, based on breakthrough iPS cells
  • Bionos provides efficacy testing for Cosmetic and Food-Nutraceutical industries, mainly in in vitro and ex vivo bioassays, by using cutting-edge equipment and techniques at their facilities at the Hospital La Fe in Valencia, Spain.

These three partnerships complement Eurofins Cosmetics & Personal Care's current global offering and form part of the companies’ global strategy to provide a one-stop shop solution and deliver superior and sustainable solutions.

For further information:

Sarah Bachir-Levy

SarahBachir-Levy@eurofins.com

 

About Eurofins – the global leader in bio-analysis

Eurofins is Testing for Life. With 58,000 staff across a network of 900 laboratories in 54 countries, Eurofins’ companies offer a portfolio of over 200,000 analytical methods.

Eurofins Shares are listed on Euronext Paris Stock Exchange. Further information: www.eurofins.com

 

About Eurofins Cosmetics & Personal Care – the global leader in Cosmetics & Personal Care testing

Eurofins Cosmetics & Personal Care is a leading provider in cosmetics and personal care testing worldwide, offering the most comprehensive service portfolio from its state-of-the-art cosmetics testing laboratories across the globe. With a network of over 29 high-level laboratories active in the field across Europe, North America, Asia, Australia and Africa, Eurofins Cosmetics & Personal Care offers an unmatched range of services to both top-tier international and local clients, including: regulatory and toxicological services, physico-chemical analyses, microbiology, ecotoxicity and biodegradability, in vitro testing, clinical studies, consumer tests and sensory evaluation, and audit and consulting services. Further information: www.eurofins.com/cos

 

About CTIBIOTECH – Cell Therapy Research Institute

CTIBIOTECH develops and produces predictive models of human tissues and cells for biomedical, pharmaceutical and dermatocosmetic research and development. CTIBIOTECH hosts a team of worldclass experts who have pioneered innovation in bioengineering and regenerative medicine over the past 30 years. CTIBIOTECH partners with public and private organizations to develop innovative solutions for the efficacy and safety testing of active ingredients, dermatocosmetics, drug candidates, cell therapies and medical devices. Further information: www.ctibiotech.com

 

About Phenocell – Contract Research Organization

 

Phenocell is an R&D company specialized in the design of phenotypic assays for cosmetic and pharmaceutical research using the Nobel Prize winning technology of iPS cells.​ Phenocell develops high throughput bioassays with unique reproducibility due to unlimited availability of iPSC-derived human cells.​ Phenotypic assays are used to repurpose existing drugs/ingredients and discover or validate tomorrow’s innovations. Further information: www.phenocell.com

 

About Bionos – Contract Research Organization

 

Bionos Biotech S.L.is a leading company specialized in Efficacy Testing for Cosmetic and Food-Nutraceutical industries (in vitro, ex vivo & in vivo Bioassays), located in the facilities of the Biopolo of new Hospital La Fe in Valencia.

Bionos’ mission is to help cosmetic and food companies in their R&D activities, through advice, design and development of efficacy and functionality bioassays on final product and active ingredients. Through the scientific know-how acquired after more than 25 years of experience in research, Bionos designes and develops personalized assays in order to validate the efficacy and functionality of the final products and/or their active ingredients. Further information: www.bionos.es